CoMentis
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
280 Utah Ave Ste 275, South San Francisc...Phone Number
(650) 869-7600Website
www.comentis.comRevenue
$10.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About CoMentis
CoMentis, Inc. is focused on the research and development of small molecule drugs to treat CNS disorders. The company, with headquarters in South San Francisco, was founded based on the groundbreaking discoveries on structure, function, and inhibition of the beta-secretase enzyme by Jordan Tang, Ph.D., J.G. Puterbaugh Chair in Biomedical Research at the Oklahoma Medical Research Foundation and Arun K. Ghosh, Ph.D., Ian P. Rothwell Distinguished Professor - Organic Chemistry/Medicinal Chemistry at Purdue University. CoMentis is developing an orally administered disease-modifying treatment for Alzheimer's disease that inhibits the beta-secretase enzyme to reduce the formation of beta amyloid peptides, thereby preventing deleterious effects of accumulated amyloid peptides and downstream pathologies. Beta amyloid peptides aggregate to form soluble polymers and insoluble plaques in the brain, implicated in the development of Alzheimer's disease. Inhibition of beta-secretase reduces amyloidRead more
CoMentis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CoMentis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on CoMentis recently announced quarterly report
Click to see if CoMentis had a recent Job posting/layoffs
Check if CoMentis has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once CoMentis has new funding data
CoMentis, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when CoMentis launches new products
Website visits: Recent activity has been detected on your website
Check out if CoMentis is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at CoMentis
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined CoMentis as Masked Content
Find 3 more new buyers
Compare Similar Companies to CoMentis
Compare insights from companies similar to CoMentis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CoMentis is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CoMentis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CoMentis.
CoMentis financials insights
Gather financial insights about CoMentis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2005
Series A
$7M
2006
Series B
$50M
2007
Series C
$12M
2008
Series D
$20M
2016
Series E
$4.5M
CoMentis Tech Stack
A closer look at the technologies used by CoMentis
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding CoMentis
Sign Up For FreeTo access detailed company insights
CoMentis, Inc. is focused on the research and development of small molecule drugs to treat CNS disorders. The company, with headquarters in South San Francisco, was founded based on the groundbreaking discoveries on structure, function, and inhibition of the beta-secretase enzyme by Jordan Tang, Ph.D., J.G. Puterbaugh Chair in Biomedical Research a... Read More
